Stryker Corporation (SYK)
NYSE: SYK · Real-Time Price · USD
388.08
+7.16 (1.88%)
At close: May 12, 2025, 4:00 PM
388.08
0.00 (0.00%)
After-hours: May 12, 2025, 7:00 PM EDT
Stryker Revenue
Stryker had revenue of $5.87B in the quarter ending March 31, 2025, with 11.88% growth. This brings the company's revenue in the last twelve months to $23.22B, up 10.76% year-over-year. In the year 2024, Stryker had annual revenue of $22.60B with 10.23% growth.
Revenue (ttm)
$23.22B
Revenue Growth
+10.76%
P/S Ratio
6.37
Revenue / Employee
$438,075
Employees
53,000
Market Cap
148.31B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 22.60B | 2.10B | 10.23% |
| Dec 31, 2023 | 20.50B | 2.05B | 11.11% |
| Dec 31, 2022 | 18.45B | 1.34B | 7.84% |
| Dec 31, 2021 | 17.11B | 2.76B | 19.21% |
| Dec 31, 2020 | 14.35B | -533.00M | -3.58% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 410.06B |
| Johnson & Johnson | 89.33B |
| Merck & Co. | 63.92B |
| AbbVie | 57.37B |
| AstraZeneca | 54.98B |
| Novartis AG | 53.22B |
| Eli Lilly and Company | 49.00B |
| Novo Nordisk | 43.92B |
SYK News
- 3 days ago - Stryker: Mako Spine And Shoulder Launching Is On Track (Downgrade To Hold) - Seeking Alpha
- 4 days ago - Stryker declares an $0.84 per share quarterly dividend - GlobeNewsWire
- 10 days ago - Stryker Corporation (SYK) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 11 days ago - Stryker beats quarterly estimates of string medical device demand - Reuters
- 11 days ago - Stryker reports first quarter 2025 operating results - GlobeNewsWire
- 13 days ago - Stryker to participate in the Bank of America Securities 2025 Global Healthcare Conference - GlobeNewsWire
- 5 weeks ago - Viscogliosi Brothers Completes Acquisition of U.S. Spine Business from Stryker, Creating VB Spine, LLC - GlobeNewsWire
- 5 weeks ago - Stryker completes sale of U.S. spinal implants business - GlobeNewsWire